On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Mp Biomedicals SARL's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€116k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- HIGHGLYCANPartner
Methods for high-throughput (HTP) analysis of protein glycosylation
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€116ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 1 shared project
- The University of EdinburghUnited Kingdom · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- Genos Doo Za Vjestacenje i AnalizuCroatia · 1 shared project
- National Institute for Bioprocessing Research and Training LimitedIreland · 1 shared project
- Ludger LimitedUnited Kingdom · 1 shared project
- Sartorius Bia Separations, Separacijske Tehnologije, D.o.o.Slovenia · 1 shared project
- Glyxera GmbHGermany · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- adverse drug reactions
- carbohydrates
- diabetes
- oncology
- proteomics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗